Skip to content
Clinical Trials – home
GreeceBack to Greece

Clinical trials in Νikaia – page 29

1 033 clinical trials in Νikaia, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.

GreeceOur site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)
Νikaia at a glance
1 033
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 033 trials in Νikaia

Open in trial search

B-cell lymphoma+1

Recruiting

Long-term Study of Ibrutinib for Patients with B-cell Non-Hodgkin's Lymphoma and Chronic Graft Versus Host Disease

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:Janssen Cilag International

Study on Anakinra for Patients with Long COVID and Ongoing Respiratory Symptoms

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Hellenic Institute For The Study Of Sepsis

Study on Monitoring Untreated Multiple Myeloma in Patients Using Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone or a New Drug Combination

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Emn Trial Office S.r.l. Impresa Sociale

Study on Elacestrant for Treating ER+/HER2- Breast Cancer in Patients with ctDNA Relapse

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Europese Organisatie Voor Onderzoek En Behandeling Van Kanker Organisation Europeenne Pour La Recherche Et Le Traitement Du Cancer European Organi

Study on Lutetium (177Lu) Vipivotide Tetraxetan to Delay Recurrence in Adult Men with PSMA-Positive Oligometastatic Prostate Cancer

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Gozetotide
  • Sponsor:Novartis Pharma AG

Breast cancer

Recruiting

Study on Optimizing CDK 4/6 Inhibitors and Endocrine Therapy for Older Patients with Advanced Breast Cancer Using Abemaciclib, Palbociclib, and Ribociclib

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:65+ years
  • Substances:Abemaciclib
  • Sponsor:Region Oerebro Laen

Study Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on Long-Term Safety of Inclisiran for Patients with Familial Hypercholesterolemia Who Completed Previous Adolescent Studies

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:0–17 years · 18–64 years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Study on the Effectiveness and Safety of Dapirolizumab Pegol for Patients with Moderate to Severe Systemic Lupus Erythematosus

Registered drug
Countries:GreeceGreece
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anhydrous Caffeine
  • Sponsor:UCB Biopharma

Study on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anhydrous Caffeine
  • Sponsor:UCB Biopharma

Study on the Effectiveness and Safety of Lifileucel and Pembrolizumab for Patients with Untreated, Unresectable, or Metastatic Melanoma

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Aldesleukin
  • Sponsor:Iovance Biotherapeutics Inc.

Neoplasm

Recruiting

Continued Cancer Treatment Study with Abiraterone, Ipatasertib, Tiragolumab, and Drug Combination for Patients from Previous Genentech/Roche Trials

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Greece

The busiest research cities in the country

All 48 cities in Greece

Clinical research in Νikaia

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on heart failure prevention and arterial hypertension management. Research includes evaluation of combination therapies to reduce cardiovascular risks and improve patient outcomes.

  • Heart Failure Prevention
  • Blood Pressure Management
  • Cardiovascular Risk Assessment

Novel combination treatments are being tested to enhance therapeutic effectiveness in cardiovascular conditions.

02 Gastroenterology Studies

Comprehensive research into inflammatory bowel diseases, including Crohn's Disease and Ulcerative Colitis. Studies evaluate new therapeutic approaches for moderate to severe cases.

  • Inflammatory Bowel Disease Management
  • Long-term Treatment Efficacy
  • Combination Therapy Approaches

Advanced treatments are being investigated to improve disease control and patient quality of life.

03 Endocrine and Renal Research

Specialized studies examining Cushing's Syndrome and IgA Nephropathy. Research focuses on controlling hyperglycemia and evaluating long-term treatment safety.

  • Metabolic Disorder Management
  • Renal Disease Therapeutics
  • Endocrine System Treatments

Innovative therapeutic approaches are being developed for complex endocrine and kidney conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.